About
Chris Vernall is the Executive Vice President of Business Development at HCmed, UK, supporting customers worldwide in advancing inhaled medicines using HCmed’s proprietary mesh nebuliser technologies. A chemist by training, he holds Master’s degrees in Medicinal and Pharmaceutical Chemistry and Executive Leadership.
With extensive experience across respiratory-focused CROs and drug delivery companies, Mr Vernall is passionate about inhaled drug development and actively advises on technical and commercial strategy, also leading industry forums and committees in inhaled biologics.